We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+18.49%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$1.78B
AUM Growth
+$242M
(+16%)
Cap. Flow
-$5.15M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
52.41%
Holding
310
New
14
Increased
56
Reduced
56
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$44.9M |
| 2 |
West Pharmaceutical
WST
|
+$3.89M |
| 3 |
Rockwell Automation
ROK
|
+$3.51M |
| 4 |
Adobe
ADBE
|
+$3.37M |
| 5 |
Apple
AAPL
|
+$2.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$37M |
| 2 |
NVIDIA
NVDA
|
+$9M |
| 3 |
Amazon
AMZN
|
+$6.64M |
| 4 |
EPAM Systems
EPAM
|
+$6.47M |
| 5 |
Public Storage
PSA
|
+$5.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.49% |
| 2 | Healthcare | 15.9% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Communication Services | 9.44% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AbbVie
ABBV
$465B
| $544K | 0.03% |
4,037
| – | – |
|
152
SentinelOne
S
$6.35B
| $515K | 0.03% |
34,075
+1,646
| +5% | +$27.8K |
|
153
Broadcom
AVGO
$1.76T
| $492K | 0.03% |
5,670
| – | – |
|
154
ExxonMobil
XOM
$650B
| $466K | 0.03% |
4,345
| – | – |
|
155
Cisco
CSCO
$443B
| $452K | 0.03% |
8,736
| – | – |
|
156
Chevron
CVX
$382B
| $411K | 0.02% |
2,615
| – | – |
|
157
Johnson & Johnson
JNJ
$640B
| $409K | 0.02% |
2,471
| – | – |
|
158
Procter & Gamble
PG
$340B
| $381K | 0.02% |
2,513
| – | – |
|
159
Verizon
VZ
$197B
| $360K | 0.02% |
9,687
| – | – |
|
160
Philip Morris
PM
$309B
| $318K | 0.02% |
3,212
| – | – |
|
161
Coca-Cola
KO
$383B
| $316K | 0.02% |
5,209
| – | – |
|
162
Intel
INTC
$413B
| $314K | 0.02% |
9,404
| – | – |
|
|
DOCU
163
DocuSign
DOCU
$11.1B
| $282K | 0.02% |
5,525
+148
| +3% | +$7.84K |
|
164
Amgen
AMGN
$209B
| $276K | 0.02% |
1,245
| – | – |
|
165
Altria Group
MO
$125B
| $276K | 0.02% |
5,966
| – | – |
|
166
AT&T
T
$164B
| $269K | 0.02% |
16,849
| – | – |
|
167
Caterpillar
CAT
$361B
| $265K | 0.01% |
1,076
| – | – |
|
168
Paychex
PAYX
$43.4B
| $236K | 0.01% |
2,108
| – | – |
|
169
Snap
SNAP
$7.96B
| $228K | 0.01% |
19,295
+517
| +3% | +$5.19K |
|
170
Microchip Technology
MCHP
$38.8B
| $226K | 0.01% |
2,518
| – | – |
|
171
HP
HPQ
$26B
| $214K | 0.01% |
6,925
| – | – |
|
172
KLA
KLAC
$222B
| $206K | 0.01% |
4,240
| – | – |
|
173
RTX Corp
RTX
$290B
| $191K | 0.01% |
1,948
| – | – |
|
174
Waste Management
WM
$95B
| $181K | 0.01% |
1,044
| – | – |
|
175
PepsiCo
PEP
$196B
| $180K | 0.01% |
971
| – | – |
|
Similar funds
ZF
AG
NRCM
CWM
BAM
PFM
DMIC
LIP
Silvant Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Silvant Capital Management held 310 positions worth $1.78B, up 16% from $1.54B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Silvant Capital Management's Q2 2023 filing shows 14 new, 56 increased, 56 reduced and 5 closed positions. Its largest new stake was West Pharmaceutical: 10,893 shares worth $4.17M. The largest sale was Estee Lauder, an estimated $37M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Silvant Capital Management's largest Q2 2023 buy was West Pharmaceutical: 10,893 shares worth $4.17M.
- Silvant Capital Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $44.9M increase.
- Silvant Capital Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $9M.
- Silvant Capital Management fully exited Estee Lauder in Q2 2023, selling an estimated $37M.
- Silvant Capital Management's ten largest holdings make up 52% of its $1.78B portfolio in Q2 2023.
- Silvant Capital Management opened 14 new positions and closed 5 in Q2 2023.
- Silvant Capital Management's portfolio value rose 16% quarter-over-quarter to $1.78B.
Based on Silvant Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.